Developing a universal vaccine to protect against influenza.
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
This study is looking for people to help test a new flu vaccine that could protect against more types of the flu for a longer time, so if you’re interested in helping improve flu prevention, this might be for you!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10819411 on NIH RePORTER |
What this research studies
This research focuses on creating a universal influenza vaccine that aims to provide broader and longer-lasting protection against various strains of the flu virus. The approach involves collaboration among multiple centers to innovate and test new vaccine formulations and strategies. Patients may participate in clinical trials that assess the safety and effectiveness of these new vaccines, contributing to advancements in flu prevention.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals of all ages who are at risk for influenza, particularly those with underlying health conditions or weakened immune systems.
Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a universal flu vaccine that significantly reduces the incidence of influenza and its complications.
How similar studies have performed: Other research efforts have shown promise in developing universal flu vaccines, indicating that this approach has potential for success.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Walter, Emmanuel — Duke University
- Study coordinator: Walter, Emmanuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.